These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 18812464

  • 1. Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.
    Govoni KE, Wergedal JE, Chadwick RB, Srivastava AK, Mohan S.
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1172-80. PubMed ID: 18812464
    [Abstract] [Full Text] [Related]

  • 2. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models.
    Callewaert F, Venken K, Kopchick JJ, Torcasio A, van Lenthe GH, Boonen S, Vanderschueren D.
    J Bone Miner Res; 2010 Mar; 25(3):617-26. PubMed ID: 19888832
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.
    Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ.
    Endocrinology; 2003 Mar; 144(3):929-36. PubMed ID: 12586770
    [Abstract] [Full Text] [Related]

  • 4. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis.
    Venken K, Schuit F, Van Lommel L, Tsukamoto K, Kopchick JJ, Coschigano K, Ohlsson C, Movérare S, Boonen S, Bouillon R, Vanderschueren D.
    J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production.
    Courtland HW, Sun H, Beth-On M, Wu Y, Elis S, Rosen CJ, Yakar S.
    J Bone Miner Res; 2011 Apr; 26(4):761-8. PubMed ID: 20928887
    [Abstract] [Full Text] [Related]

  • 6. Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immune response in C57BL/6J mice.
    Rendina E, Lim YF, Marlow D, Wang Y, Clarke SL, Kuvibidila S, Lucas EA, Smith BJ.
    J Nutr Biochem; 2012 Jan; 23(1):60-8. PubMed ID: 21414765
    [Abstract] [Full Text] [Related]

  • 7. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.
    Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S.
    Endocrinology; 2007 Dec; 148(12):5706-15. PubMed ID: 17717052
    [Abstract] [Full Text] [Related]

  • 8. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M.
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [Abstract] [Full Text] [Related]

  • 9. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
    Han X, Xu Y, Wang J, Pei X, Yang R, Li N, Li Y.
    Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
    [Abstract] [Full Text] [Related]

  • 10. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways.
    Syed FA, Mödder UI, Fraser DG, Spelsberg TC, Rosen CJ, Krust A, Chambon P, Jameson JL, Khosla S.
    J Bone Miner Res; 2005 Nov; 20(11):1992-2001. PubMed ID: 16234973
    [Abstract] [Full Text] [Related]

  • 11. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy.
    Yeh JK, Chen MM, Aloia JF.
    Am J Physiol; 1997 Oct; 273(4):E734-42. PubMed ID: 9357803
    [Abstract] [Full Text] [Related]

  • 12. The effect of ovariectomy and ovarian steroid treatment on growth hormone and insulin-like growth factor-I levels in the rat femur.
    Suliman IA, El-Bakri NK, Adem A, Mustafa A, Lindgren JU.
    J Orthop Res; 2001 Nov; 19(6):1008-12. PubMed ID: 11780998
    [Abstract] [Full Text] [Related]

  • 13. Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice.
    Kasukawa Y, Baylink DJ, Wergedal JE, Amaar Y, Srivastava AK, Guo R, Mohan S.
    Endocrinology; 2003 Nov; 144(11):4682-9. PubMed ID: 12960002
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.
    Murphy LJ, Friesen HG.
    Endocrinology; 1988 Jan; 122(1):325-32. PubMed ID: 3335211
    [Abstract] [Full Text] [Related]

  • 15. Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice.
    Kasukawa Y, Baylink DJ, Guo R, Mohan S.
    Endocrinology; 2003 Sep; 144(9):3950-7. PubMed ID: 12933669
    [Abstract] [Full Text] [Related]

  • 16. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R, Sheikh S, Nawaz A, Napoli N, Mueller C, Halstead LR, Brodt MD, Silva MJ, Galbiati E, Caruso PL, Civelli M, Civitelli R.
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [Abstract] [Full Text] [Related]

  • 17. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L, Härkönen P, Väänänen K, Peng Z.
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [Abstract] [Full Text] [Related]

  • 18. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.
    Lindberg MK, Svensson J, Venken K, Chavoshi T, Andersson N, Movérare Skrtic S, Isaksson O, Vanderschueren D, Carlsten H, Ohlsson C.
    Bone; 2006 Jan; 38(1):85-92. PubMed ID: 16257281
    [Abstract] [Full Text] [Related]

  • 19. Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice.
    Govoni KE, Lee SK, Chung YS, Behringer RR, Wergedal JE, Baylink DJ, Mohan S.
    Physiol Genomics; 2007 Aug 20; 30(3):354-62. PubMed ID: 17519362
    [Abstract] [Full Text] [Related]

  • 20. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun 20; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.